Caris Life Sciences revenue was $907.29M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $216.2M, down 26.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CAI annual revenue was $812.0M, with 97% growth year-over-year.
CAI past revenue growth
How has CAI's revenue growth performed historically?
Caris Life Sciences (NASDAQ: CAI) reported Q1 2026 revenue of $216.17 million up 78.78% year over year. In the same quarter last year, Caris Life Sciences's revenue was $120.92 million.
What was Caris Life Sciences's revenue in 2025?
Caris Life Sciences's annual revenue for the twelve months ending Dec 31, 2025 was $812.03 million, a 96.97% increase year over year.
How much does Caris Life Sciences make in a day?
Based on Caris Life Sciences annual revenue for the past two years, CAI makes an average of $1,677,113.70 per day.
What was Caris Life Sciences's annual revenue growth in the past year?
As of Q2 2026, Caris Life Sciences's revenue has grown 100.51% year over year. This is 162.05 percentage points lower than the US Biotechnology industry revenue growth rate of 262.56%. Caris Life Sciences's revenue in the past year totaled $907.29 million.
How much does Caris Life Sciences make in a year?
Caris Life Sciences's revenue by year for the past two years is:
Caris Life Sciences's revenue for the twelve months ending Dec 31, 2025 was $812.03 million, a 96.97% increase year over year.
Caris Life Sciences's annual revenue for Dec 31, 2024 was $412.26 million, a 34.67% increase from 2023.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.